Altisource Asset Management Corp (NYSEMKT:AAMC), major shareholder Luxor Capital Group, Lp acquired 2,371 shares of the company’s stock in a transaction that occurred on Friday, May 30th. The stock was purchased at an average price of $964.35 per share, for a total transaction of $2,286,473.85. The acquisition was disclosed in a document filed with the SEC, which is available at this link. Major shareholders that own at least 10% of a company’s stock are required to disclose their sales and purchases with the SEC. Altisource Asset Management Corp (NYSEMKT:AAMC), net profit margin is 1.70% and weekly performance is -11.81%. On last trading day company shares ended up $723.06. Altisource Asset Management Corp (NYSEMKT:AAMC), distance from 50-day simple moving average (SMA50) is -23.92%.
Applied Genetic Technologies Corp (NASDAQ:AGTC), announced that it has appointed David R. Guyer, MD, and Ivana Magovcevic-Liebisch, PhD, JD, to the company’s Board of Directors. Applied Genetic Technologies Corp (NASDAQ:AGTC), fell 8.26% in last trading session and ended the day on $23.10. AGTC, return on assets is -60.40%. Applied Genetic Technologies Corp (NASDAQ:AGTC), quarterly performance is 54.00%.
On June 03, 2014, Theravance and Theravance Biopharma Inc (NASDAQ:TBPH), have announced the completion of the separation of Theravance Biopharma, the research and development-based biopharmaceutical business, from Theravance. to form two, independent, publicly traded companies with differing business objectives and opportunities, via a dividend distribution of Theravance Biopharma shares to Theravance stockholders. Theravance Biopharma Inc (NASDAQ:TBPH), shares moved down 6.81% in last trading session and was closed at $31.88, while trading in range of $31.02 – 35.00. Theravance Biopharma Inc (NASDAQ:TBPH), year to date (YTD) performance is 38.85%.
Stock analysts at RBC Capital assumed coverage on shares of Transenterix Inc (NYSEMKT:TRXC), in a report issued on Tuesday. The firm set an “outperform” rating and a $6.00 price target on the stock. RBC Capital’s target price indicates a potential upside of 71.43% from the stock’s previous close. Transenterix Inc (NYSEMKT:TRXC), ended the last trading day at $5.04. Company weekly volatility is calculated as 11.62% and price to cash ratio as 36.48. Transenterix Inc (NYSEMKT:TRXC), showed a negative weekly performance of 13.56%.
First Analysis upgraded shares of Career Education Corp. (NASDAQ:CECO), from an underweight rating to an equal weight rating in a report issued on Wednesday,TheFlyOnTheWall.com reports. Career Education Corp. (NASDAQ:CECO), net profit margin is -21.90% and weekly performance is -4.29%. On last trading day company shares ended up $4.68. Analysts mean target price for the company is $5.50. Career Education Corp. (NASDAQ:CECO), distance from 50-day simple moving average (SMA50) is -14.75%.